Nectar Lifesciences Limited (NECLIFE.NS)
INR 23.27
(4.58%)
INR 23.27
(4.58%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 21.91 Billion INR | 0.08% |
| 2022 | 21.89 Billion INR | -8.43% |
| 2021 | 23.9 Billion INR | -3.25% |
| 2020 | 24.71 Billion INR | -6.16% |
| 2019 | 26.33 Billion INR | -2.65% |
| 2018 | 27.04 Billion INR | -0.69% |
| 2017 | 27.23 Billion INR | 5.54% |
| 2016 | 25.8 Billion INR | -2.39% |
| 2015 | 26.44 Billion INR | 5.32% |
| 2014 | 25.1 Billion INR | 4.86% |
| 2013 | 23.94 Billion INR | 5.28% |
| 2012 | 22.74 Billion INR | 7.22% |
| 2011 | 21.2 Billion INR | 17.01% |
| 2010 | 18.12 Billion INR | 22.43% |
| 2009 | 14.8 Billion INR | 15.16% |
| 2008 | 12.85 Billion INR | 35.54% |
| 2007 | 9.48 Billion INR | 22.06% |
| 2006 | 7.77 Billion INR | 69.91% |
| 2005 | 4.57 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 21.42 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 21.91 Billion INR | 0.0% |
| 2023 FY | 21.91 Billion INR | 0.08% |
| 2022 Q2 | 22.88 Billion INR | 0.0% |
| 2022 Q4 | 21.89 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 21.89 Billion INR | -8.43% |
| 2021 Q4 | 23.9 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 23.9 Billion INR | -3.25% |
| 2021 Q2 | 23.68 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 24.71 Billion INR | -6.16% |
| 2020 Q2 | 25.34 Billion INR | 0.0% |
| 2020 Q4 | 24.71 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q4 | 26.33 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 26.33 Billion INR | -2.65% |
| 2019 Q2 | 27.05 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q4 | 27.04 Billion INR | 0.0% |
| 2018 FY | 27.04 Billion INR | -0.69% |
| 2017 FY | 27.23 Billion INR | 5.54% |
| 2016 FY | 25.8 Billion INR | -2.39% |
| 2015 FY | 26.44 Billion INR | 5.32% |
| 2014 FY | 25.1 Billion INR | 4.86% |
| 2013 FY | 23.94 Billion INR | 5.28% |
| 2012 FY | 22.74 Billion INR | 7.22% |
| 2011 FY | 21.2 Billion INR | 17.01% |
| 2010 FY | 18.12 Billion INR | 22.43% |
| 2009 FY | 14.8 Billion INR | 15.16% |
| 2008 FY | 12.85 Billion INR | 35.54% |
| 2007 FY | 9.48 Billion INR | 22.06% |
| 2006 FY | 7.77 Billion INR | 69.91% |
| 2005 FY | 4.57 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | 9.921% |
| Albert David Limited | 4.97 Billion INR | -339.979% |
| Alembic Limited | 23.28 Billion INR | 5.914% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -4553.634% |
| Hester Biosciences Limited | 6.62 Billion INR | -230.802% |
| Hikal Limited | 24.87 Billion INR | 11.905% |
| Ind-Swift Limited | 6.54 Billion INR | -234.783% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -812.706% |
| Unichem Laboratories Limited | 31.69 Billion INR | 30.867% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 66.007% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -1383.635% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -186.365% |
| Brooks Laboratories Limited | 904.45 Million INR | -2322.518% |
| Eris Lifesciences Limited | 70.48 Billion INR | 68.916% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | 6.628% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -909.341% |
| Wanbury Limited | 3.43 Billion INR | -537.875% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 15.144% |
| Alkem Laboratories Limited | 155.74 Billion INR | 85.932% |
| FDC Limited | 24.68 Billion INR | 11.225% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 23.132% |
| Gufic Biosciences Limited | 10.92 Billion INR | -100.547% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -88.056% |
| Innova Captab Limited | 13.2 Billion INR | -65.878% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 2.377% |
| Ipca Laboratories Limited | 111.01 Billion INR | 80.263% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 81.027% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -212.878% |
| Lupin Limited | 239.97 Billion INR | 90.87% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -557.138% |
| Medico Remedies Limited | 961.95 Million INR | -2177.717% |
| Morepen Laboratories Limited | 12.93 Billion INR | -69.428% |
| Orchid Pharma Limited | 15.53 Billion INR | -41.006% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -175.827% |
| RPG Life Sciences Limited | 5.12 Billion INR | -327.215% |
| Sigachi Industries Limited | 6.94 Billion INR | -215.643% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 97.436% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 2.796% |
| Themis Medicare Limited | 5.66 Billion INR | -286.828% |
| Vaishali Pharma Limited | 799.55 Million INR | -2640.338% |
| Venus Remedies Limited | 6.26 Billion INR | -249.546% |
| Windlas Biotech Limited | 6.26 Billion INR | -249.894% |
| ZIM Laboratories Limited | 4.46 Billion INR | -390.364% |
| Sakar Healthcare Limited | 3.88 Billion INR | -463.748% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 95.139% |
| Divi's Laboratories Limited | 154.7 Billion INR | 85.837% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -103.247% |
| Mankind Pharma Limited | 119.63 Billion INR | 81.685% |
| Sequent Scientific Limited | 15.4 Billion INR | -42.241% |
| Laurus Labs Limited | 83.87 Billion INR | 73.876% |
| Neuland Laboratories Limited | 18.32 Billion INR | -19.563% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 45.143% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 84.74% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 92.517% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -497.228% |
| Wockhardt Limited | 76.49 Billion INR | 71.355% |
| Bal Pharma Limited | 3.2 Billion INR | -583.874% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 94.346% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -80.502% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -2056.316% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 18.771% |
| Shilpa Medicare Limited | 30.93 Billion INR | 29.165% |
| Valiant Laboratories Limited | 3.42 Billion INR | -539.375% |
| Ajanta Pharma Limited | 46.38 Billion INR | 52.763% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -618.398% |
| Granules India Limited | 55.2 Billion INR | 60.314% |
| Medicamen Biotech Limited | 2.94 Billion INR | -643.935% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -441.451% |
| Piramal Enterprises Limited | 826.05 Billion INR | 97.348% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 85.452% |
| NATCO Pharma Limited | 69.06 Billion INR | 68.275% |
| Suven Life Sciences Limited | 2.84 Billion INR | -669.054% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1129.724% |
| Strides Pharma Science Limited | 58.39 Billion INR | 62.48% |
| Indoco Remedies Limited | 21.44 Billion INR | -2.16% |
| Alpa Laboratories Limited | 1.82 Billion INR | -1099.779% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -1352.293% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -325.415% |